Structure-activity relationships among some antiinflammatory 3-(5-aryl-2-tetrazolyl)alkanoic acids and derivatives.
D000085:Acetates / Q000008:administration & dosage / Q000627:therapeutic use; D000284:Administration, Oral; D000577:Amides / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001393:Azoles / Q000008:administration & dosage / Q000627:therapeutic use*; D002351:Carrageenan; D007509:Irritants; D008956:Models, Chemical; D010653:Phenylbutazone / Q000627:therapeutic use; D010998:Pleurisy / Q000139:chemically induced / Q000188:drug therapy; D011422:Propionates / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D013329:Structure-Activity Relationship
D000085:Acetates; D000577:Amides; D000893:Anti-Inflammatory Agents; D001393:Azoles; D007509:Irritants; D011422:Propionates; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin